Quinine alone versus Quinine Plus a Pyrimethamine-Sulfadoxine Combination in the Treatment of Plasmodium Faliciparum Cerebral Malaria
Yaakov Naparstek, D. Weiler-Ravell, Joshua Shemer, D. Englehard, Jessica Sack, Dan T. Spira, J. Adler
Abstract
Yaakov Naparstek, D. Weiler-Ravell, Joshua Shemer, D. Englehard, Jessica Sack, Dan T. Spira, J. Adler
Abstract
Fifty-two patients with severe chloroquine resistant Plasmodium falciparum malaria were treated in a randomized double blind study with either quinine and a single dose of pyrimethamine-sulfadoxine (Fansidar) or quinine alone. Although no statistically significant differences were observed, the 25 patients who received both drugs responded faster and had a more favorable outcome (no deaths) when compared to the 27 who received quinine alone (2 deaths).
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Fifty-two patients with severe chloroquine resistant Plasmodium falciparum malaria were treated in a randomized double blind study with either quinine and a single dose of pyrimethamine-sulfadoxine (Fansidar) or quinine alone. Although no statistically significant differences were observed, the 25 patients who received both drugs responded faster and had a more favorable outcome (no deaths) when compared to the 27 who received quinine alone (2 deaths).
Key concepts: Quinine, Pyrimethamine, Sulfadoxine, Malaria, Cerebral Malaria, Medicine, Sulfadoxine/pyrimethamine, Plasmodium falciparum